Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Embody vs Mondae

Embody
Site position #52

Higher grade

Mondae
Site position #70

Lower grade

The verdict

Embody takes it — 76.5/100 to 74.3/100.

Embody grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Embody is a low-cost injection option, but the modest prepaid savings deserve a close look beside its payment-finality and renewal rules.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMondae +2
88
90
Dose & formulationEmbody +19
83
64
Clinical oversightEmbody +11
83
72
Labs & monitoringEmbody +2
54
52
FulfillmentEmbody +4
93
89
Contract termsMondae +52
25
77
Embody · top barMondae · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEmbodyMondae
WeighScore76.5/10074.3/100
GradeCC
Site position#52#70
Semaglutide$79/mo (one-month injection; $828 annual prepay equals $69/mo)$87 per 28 days (thirteen charges a year; $75/mo requires a three-month prepay)
Tirzepatide$129/mo (one-month injection; $1,428 annual prepay equals $119/mo)$126 per 28 days (thirteen charges a year; $124/mo requires a three-month prepay)
CoverageState eligibility not fully published; confirm your locationAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Embody

Site position #52 · C

Strengths

  • One-month injection offers at $79 semaglutide and $129 tirzepatide
  • Separate monthly, three-, six- and twelve-month price tiers published
  • OpenLoop care network and four pharmacy partners publicly named; individual assignment still needs confirmation

What to consider

  • Payments are described as final at purchase except provider-initiated medical disqualification, with used services deducted
  • Cancel at least 72 hours before renewal; unused prepaid months are not routinely refundable
  • Homepage week counts differ from product month labels; confirm supply and charge dates
  • Current catalog supports injections; no active oral-gum offer or universal state footprint confirmed
Mondae

Site position #70 · C

Strengths

  • $87 and $126 per cycle are at the low end of what this ranking records for either molecule
  • No membership or consultation fee is charged, stated on the checkout itself rather than in marketing copy
  • Free shipping, and support hours are published as 8:00 AM to 8:00 PM Eastern
  • A priced injectable peptide menu sits beside the GLP-1 lines

What to consider

  • A Mondae month is 28 days — the intake says shipped and billed every 28 days, which is thirteen charges a year
  • The homepage figures “from $75” and “from $124” are three-month prepay rates; the month-to-month rates are $87 and $126
  • The hero reads “prices start from $87” above a grid whose lowest figure is $63
  • The peptide rows are labeled billed monthly under three-month rates
  • A pharmacy, Greenwich, is named on the sermorelin, NAD+ and glutathione pages and on neither GLP-1 page — the compounder for the drug this row is about is not disclosed
  • No clinician, medical group or NPI is named; the Terms name a telehealth platform only
  • Shipping is quoted at about two days in the plan FAQ and five to seven business days in the shipping policy

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard